GFAP and central nervous system cancer: An alternative cre line that is commonly used in glioma GEMMs is hGFAP-cre (driven by the human glial fibrillary acidic protein promoter), which is also expressed from pre-natal stages and in the majority of cell types in the brain and spinal cord [33].